Fabio Arturo Iannotti, Charlotte L Hill, Antonio Leo, Ahlam Alhusaini, Camille Soubrane, Enrico Mazzarella, Emilio Russo, Benjamin J Whalley, Vincenzo Di Marzo, Gary J Stephens. ACS Chem Neurosci 2014
Times Cited: 228
Times Cited: 228
Times Cited
Times Co-cited
Similarity
Effects of cannabinoids and cannabinoid-enriched Cannabis extracts on TRP channels and endocannabinoid metabolic enzymes.
Luciano De Petrocellis, Alessia Ligresti, Aniello Schiano Moriello, Marco Allarà, Tiziana Bisogno, Stefania Petrosino, Colin G Stott, Vincenzo Di Marzo. Br J Pharmacol 2011
Luciano De Petrocellis, Alessia Ligresti, Aniello Schiano Moriello, Marco Allarà, Tiziana Bisogno, Stefania Petrosino, Colin G Stott, Vincenzo Di Marzo. Br J Pharmacol 2011
31
Agonistic properties of cannabidiol at 5-HT1a receptors.
Ethan B Russo, Andrea Burnett, Brian Hall, Keith K Parker. Neurochem Res 2005
Ethan B Russo, Andrea Burnett, Brian Hall, Keith K Parker. Neurochem Res 2005
29
Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor.
R B Laprairie, A M Bagher, M E M Kelly, E M Denovan-Wright. Br J Pharmacol 2015
R B Laprairie, A M Bagher, M E M Kelly, E M Denovan-Wright. Br J Pharmacol 2015
27
Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome.
Orrin Devinsky, J Helen Cross, Linda Laux, Eric Marsh, Ian Miller, Rima Nabbout, Ingrid E Scheffer, Elizabeth A Thiele, Stephen Wright. N Engl J Med 2017
Orrin Devinsky, J Helen Cross, Linda Laux, Eric Marsh, Ian Miller, Rima Nabbout, Ingrid E Scheffer, Elizabeth A Thiele, Stephen Wright. N Engl J Med 2017
25
Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide.
T Bisogno, L Hanus, L De Petrocellis, S Tchilibon, D E Ponde, I Brandi, A S Moriello, J B Davis, R Mechoulam, V Di Marzo. Br J Pharmacol 2001
T Bisogno, L Hanus, L De Petrocellis, S Tchilibon, D E Ponde, I Brandi, A S Moriello, J B Davis, R Mechoulam, V Di Marzo. Br J Pharmacol 2001
24
The orphan receptor GPR55 is a novel cannabinoid receptor.
E Ryberg, N Larsson, S Sjögren, S Hjorth, N-O Hermansson, J Leonova, T Elebring, K Nilsson, T Drmota, P J Greasley. Br J Pharmacol 2007
E Ryberg, N Larsson, S Sjögren, S Hjorth, N-O Hermansson, J Leonova, T Elebring, K Nilsson, T Drmota, P J Greasley. Br J Pharmacol 2007
23
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders.
Orrin Devinsky, Maria Roberta Cilio, Helen Cross, Javier Fernandez-Ruiz, Jacqueline French, Charlotte Hill, Russell Katz, Vincenzo Di Marzo, Didier Jutras-Aswad, William George Notcutt,[...]. Epilepsia 2014
Orrin Devinsky, Maria Roberta Cilio, Helen Cross, Javier Fernandez-Ruiz, Jacqueline French, Charlotte Hill, Russell Katz, Vincenzo Di Marzo, Didier Jutras-Aswad, William George Notcutt,[...]. Epilepsia 2014
23
Cannabidiol attenuates seizures and social deficits in a mouse model of Dravet syndrome.
Joshua S Kaplan, Nephi Stella, William A Catterall, Ruth E Westenbroek. Proc Natl Acad Sci U S A 2017
Joshua S Kaplan, Nephi Stella, William A Catterall, Ruth E Westenbroek. Proc Natl Acad Sci U S A 2017
21
Cannabidivarin-rich cannabis extracts are anticonvulsant in mouse and rat via a CB1 receptor-independent mechanism.
T D M Hill, M-G Cascio, B Romano, M Duncan, R G Pertwee, C M Williams, B J Whalley, A J Hill. Br J Pharmacol 2013
T D M Hill, M-G Cascio, B Romano, M Duncan, R G Pertwee, C M Williams, B J Whalley, A J Hill. Br J Pharmacol 2013
21
Effect of Cannabidiol on Drop Seizures in the Lennox-Gastaut Syndrome.
Orrin Devinsky, Anup D Patel, J Helen Cross, Vicente Villanueva, Elaine C Wirrell, Michael Privitera, Sam M Greenwood, Claire Roberts, Daniel Checketts, Kevan E VanLandingham,[...]. N Engl J Med 2018
Orrin Devinsky, Anup D Patel, J Helen Cross, Vicente Villanueva, Elaine C Wirrell, Michael Privitera, Sam M Greenwood, Claire Roberts, Daniel Checketts, Kevan E VanLandingham,[...]. N Engl J Med 2018
18
The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin.
R G Pertwee. Br J Pharmacol 2008
R G Pertwee. Br J Pharmacol 2008
18
Cannabidivarin is anticonvulsant in mouse and rat.
A J Hill, M S Mercier, T D M Hill, S E Glyn, N A Jones, Y Yamasaki, T Futamura, M Duncan, C G Stott, G J Stephens,[...]. Br J Pharmacol 2012
A J Hill, M S Mercier, T D M Hill, S E Glyn, N A Jones, Y Yamasaki, T Futamura, M Duncan, C G Stott, G J Stephens,[...]. Br J Pharmacol 2012
18
Molecular Targets of the Phytocannabinoids: A Complex Picture.
Paula Morales, Dow P Hurst, Patricia H Reggio. Prog Chem Org Nat Prod 2017
Paula Morales, Dow P Hurst, Patricia H Reggio. Prog Chem Org Nat Prod 2017
16
Cannabinoid Ligands Targeting TRP Channels.
Chanté Muller, Paula Morales, Patricia H Reggio. Front Mol Neurosci 2019
Chanté Muller, Paula Morales, Patricia H Reggio. Front Mol Neurosci 2019
15
Are cannabidiol and Δ(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review.
John M McPartland, Marnie Duncan, Vincenzo Di Marzo, Roger G Pertwee. Br J Pharmacol 2015
John M McPartland, Marnie Duncan, Vincenzo Di Marzo, Roger G Pertwee. Br J Pharmacol 2015
15
Inhibition of an equilibrative nucleoside transporter by cannabidiol: a mechanism of cannabinoid immunosuppression.
Erica J Carrier, John A Auchampach, Cecilia J Hillard. Proc Natl Acad Sci U S A 2006
Erica J Carrier, John A Auchampach, Cecilia J Hillard. Proc Natl Acad Sci U S A 2006
14
Molecular characterization of a peripheral receptor for cannabinoids.
S Munro, K L Thomas, M Abu-Shaar. Nature 1993
S Munro, K L Thomas, M Abu-Shaar. Nature 1993
14
Cannabidiol is an allosteric modulator at mu- and delta-opioid receptors.
Markus Kathmann, Karsten Flau, Agnes Redmer, Christian Tränkle, Eberhard Schlicker. Naunyn Schmiedebergs Arch Pharmacol 2006
Markus Kathmann, Karsten Flau, Agnes Redmer, Christian Tränkle, Eberhard Schlicker. Naunyn Schmiedebergs Arch Pharmacol 2006
13
Cannabidiol modulates serotonergic transmission and reverses both allodynia and anxiety-like behavior in a model of neuropathic pain.
Danilo De Gregorio, Ryan J McLaughlin, Luca Posa, Rafael Ochoa-Sanchez, Justine Enns, Martha Lopez-Canul, Matthew Aboud, Sabatino Maione, Stefano Comai, Gabriella Gobbi. Pain 2019
Danilo De Gregorio, Ryan J McLaughlin, Luca Posa, Rafael Ochoa-Sanchez, Justine Enns, Martha Lopez-Canul, Matthew Aboud, Sabatino Maione, Stefano Comai, Gabriella Gobbi. Pain 2019
13
Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial.
Elizabeth A Thiele, Eric D Marsh, Jacqueline A French, Maria Mazurkiewicz-Beldzinska, Selim R Benbadis, Charuta Joshi, Paul D Lyons, Adam Taylor, Claire Roberts, Kenneth Sommerville. Lancet 2018
Elizabeth A Thiele, Eric D Marsh, Jacqueline A French, Maria Mazurkiewicz-Beldzinska, Selim R Benbadis, Charuta Joshi, Paul D Lyons, Adam Taylor, Claire Roberts, Kenneth Sommerville. Lancet 2018
13
Cannabidiol displays antiepileptiform and antiseizure properties in vitro and in vivo.
Nicholas A Jones, Andrew J Hill, Imogen Smith, Sarah A Bevan, Claire M Williams, Benjamin J Whalley, Gary J Stephens. J Pharmacol Exp Ther 2010
Nicholas A Jones, Andrew J Hill, Imogen Smith, Sarah A Bevan, Claire M Williams, Benjamin J Whalley, Gary J Stephens. J Pharmacol Exp Ther 2010
13
The direct actions of cannabidiol and 2-arachidonoyl glycerol at GABAA receptors.
T Bakas, P S van Nieuwenhuijzen, S O Devenish, I S McGregor, J C Arnold, M Chebib. Pharmacol Res 2017
T Bakas, P S van Nieuwenhuijzen, S O Devenish, I S McGregor, J C Arnold, M Chebib. Pharmacol Res 2017
13
Molecular Targets of Cannabidiol in Neurological Disorders.
Clementino Ibeas Bih, Tong Chen, Alistair V W Nunn, Michaël Bazelot, Mark Dallas, Benjamin J Whalley. Neurotherapeutics 2015
Clementino Ibeas Bih, Tong Chen, Alistair V W Nunn, Michaël Bazelot, Mark Dallas, Benjamin J Whalley. Neurotherapeutics 2015
12
Preclinical safety and efficacy of cannabidivarin for early life seizures.
Megan N Huizenga, Alberto Sepulveda-Rodriguez, Patrick A Forcelli. Neuropharmacology 2019
Megan N Huizenga, Alberto Sepulveda-Rodriguez, Patrick A Forcelli. Neuropharmacology 2019
42
Randomized, dose-ranging safety trial of cannabidiol in Dravet syndrome.
Orrin Devinsky, Anup D Patel, Elizabeth A Thiele, Matthew H Wong, Richard Appleton, Cynthia L Harden, Sam Greenwood, Gilmour Morrison, Kenneth Sommerville. Neurology 2018
Orrin Devinsky, Anup D Patel, Elizabeth A Thiele, Matthew H Wong, Richard Appleton, Cynthia L Harden, Sam Greenwood, Gilmour Morrison, Kenneth Sommerville. Neurology 2018
12
Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.
Ethan B Russo. Br J Pharmacol 2011
Ethan B Russo. Br J Pharmacol 2011
12
Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial.
Orrin Devinsky, Eric Marsh, Daniel Friedman, Elizabeth Thiele, Linda Laux, Joseph Sullivan, Ian Miller, Robert Flamini, Angus Wilfong, Francis Filloux,[...]. Lancet Neurol 2016
Orrin Devinsky, Eric Marsh, Daniel Friedman, Elizabeth Thiele, Linda Laux, Joseph Sullivan, Ian Miller, Robert Flamini, Angus Wilfong, Francis Filloux,[...]. Lancet Neurol 2016
11
Cannabidiol displays unexpectedly high potency as an antagonist of CB1 and CB2 receptor agonists in vitro.
A Thomas, G L Baillie, A M Phillips, R K Razdan, R A Ross, R G Pertwee. Br J Pharmacol 2007
A Thomas, G L Baillie, A M Phillips, R K Razdan, R A Ross, R G Pertwee. Br J Pharmacol 2007
11
Vanilloid TRPV1 receptor mediates the antihyperalgesic effect of the nonpsychoactive cannabinoid, cannabidiol, in a rat model of acute inflammation.
Barbara Costa, Gabriella Giagnoni, Chiara Franke, Anna Elisa Trovato, Mariapia Colleoni. Br J Pharmacol 2004
Barbara Costa, Gabriella Giagnoni, Chiara Franke, Anna Elisa Trovato, Mariapia Colleoni. Br J Pharmacol 2004
11
Cannabinoid actions at TRPV channels: effects on TRPV3 and TRPV4 and their potential relevance to gastrointestinal inflammation.
L De Petrocellis, P Orlando, A Schiano Moriello, G Aviello, C Stott, A A Izzo, V Di Marzo. Acta Physiol (Oxf) 2012
L De Petrocellis, P Orlando, A Schiano Moriello, G Aviello, C Stott, A A Izzo, V Di Marzo. Acta Physiol (Oxf) 2012
11
Plant-derived cannabinoids modulate the activity of transient receptor potential channels of ankyrin type-1 and melastatin type-8.
Luciano De Petrocellis, Vittorio Vellani, Aniello Schiano-Moriello, Pietro Marini, Pier Cosimo Magherini, Pierangelo Orlando, Vincenzo Di Marzo. J Pharmacol Exp Ther 2008
Luciano De Petrocellis, Vittorio Vellani, Aniello Schiano-Moriello, Pietro Marini, Pier Cosimo Magherini, Pierangelo Orlando, Vincenzo Di Marzo. J Pharmacol Exp Ther 2008
11
TRPV2 is activated by cannabidiol and mediates CGRP release in cultured rat dorsal root ganglion neurons.
Ning Qin, Michael P Neeper, Yi Liu, Tasha L Hutchinson, Mary Lou Lubin, Christopher M Flores. J Neurosci 2008
Ning Qin, Michael P Neeper, Yi Liu, Tasha L Hutchinson, Mary Lou Lubin, Christopher M Flores. J Neurosci 2008
11
Cannabidivarin (CBDV) suppresses pentylenetetrazole (PTZ)-induced increases in epilepsy-related gene expression.
Naoki Amada, Yuki Yamasaki, Claire M Williams, Benjamin J Whalley. PeerJ 2013
Naoki Amada, Yuki Yamasaki, Claire M Williams, Benjamin J Whalley. PeerJ 2013
21
Drug-drug interaction between clobazam and cannabidiol in children with refractory epilepsy.
Alexandra L Geffrey, Sarah F Pollack, Patricia L Bruno, Elizabeth A Thiele. Epilepsia 2015
Alexandra L Geffrey, Sarah F Pollack, Patricia L Bruno, Elizabeth A Thiele. Epilepsia 2015
10
Allosteric and orthosteric pharmacology of cannabidiol and cannabidiol-dimethylheptyl at the type 1 and type 2 cannabinoid receptors.
Mylyne Tham, Orhan Yilmaz, Mariam Alaverdashvili, Melanie E M Kelly, Eileen M Denovan-Wright, Robert B Laprairie. Br J Pharmacol 2019
Mylyne Tham, Orhan Yilmaz, Mariam Alaverdashvili, Melanie E M Kelly, Eileen M Denovan-Wright, Robert B Laprairie. Br J Pharmacol 2019
10
The capsaicin receptor: a heat-activated ion channel in the pain pathway.
M J Caterina, M A Schumacher, M Tominaga, T A Rosen, J D Levine, D Julius. Nature 1997
M J Caterina, M A Schumacher, M Tominaga, T A Rosen, J D Levine, D Julius. Nature 1997
10
Non-psychoactive cannabinoids modulate the descending pathway of antinociception in anaesthetized rats through several mechanisms of action.
Sabatino Maione, Fabiana Piscitelli, Luisa Gatta, Daniela Vita, Luciano De Petrocellis, Enza Palazzo, Vito de Novellis, Vincenzo Di Marzo. Br J Pharmacol 2011
Sabatino Maione, Fabiana Piscitelli, Luisa Gatta, Daniela Vita, Luciano De Petrocellis, Enza Palazzo, Vito de Novellis, Vincenzo Di Marzo. Br J Pharmacol 2011
10
Structure of a cannabinoid receptor and functional expression of the cloned cDNA.
L A Matsuda, S J Lolait, M J Brownstein, A C Young, T I Bonner. Nature 1990
L A Matsuda, S J Lolait, M J Brownstein, A C Young, T I Bonner. Nature 1990
10
Anticonvulsant effect of cannabidiol in the pentylenetetrazole model: Pharmacological mechanisms, electroencephalographic profile, and brain cytokine levels.
Luciano R Vilela, Isabel V Lima, Érica B Kunsch, Hyorrana Priscila P Pinto, Aline S de Miranda, Érica Leandro M Vieira, Antônio Carlos P de Oliveira, Marcio Flávio D Moraes, Antônio L Teixeira, Fabricio A Moreira. Epilepsy Behav 2017
Luciano R Vilela, Isabel V Lima, Érica B Kunsch, Hyorrana Priscila P Pinto, Aline S de Miranda, Érica Leandro M Vieira, Antônio Carlos P de Oliveira, Marcio Flávio D Moraes, Antônio L Teixeira, Fabricio A Moreira. Epilepsy Behav 2017
16
Cannabidiol reduces Aβ-induced neuroinflammation and promotes hippocampal neurogenesis through PPARγ involvement.
Giuseppe Esposito, Caterina Scuderi, Marta Valenza, Giuseppina Ines Togna, Valentina Latina, Daniele De Filippis, Mariateresa Cipriano, Maria Rosaria Carratù, Teresa Iuvone, Luca Steardo. PLoS One 2011
Giuseppe Esposito, Caterina Scuderi, Marta Valenza, Giuseppina Ines Togna, Valentina Latina, Daniele De Filippis, Mariateresa Cipriano, Maria Rosaria Carratù, Teresa Iuvone, Luca Steardo. PLoS One 2011
10
10
A Phase I, Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose, Multiple Dose, and Food Effect Trial of the Safety, Tolerability and Pharmacokinetics of Highly Purified Cannabidiol in Healthy Subjects.
Lesley Taylor, Barry Gidal, Graham Blakey, Bola Tayo, Gilmour Morrison. CNS Drugs 2018
Lesley Taylor, Barry Gidal, Graham Blakey, Bola Tayo, Gilmour Morrison. CNS Drugs 2018
9
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology.
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo. Physiol Rev 2016
Alessia Ligresti, Luciano De Petrocellis, Vincenzo Di Marzo. Physiol Rev 2016
9
Effects of TRPV1 activation on synaptic excitation in the dentate gyrus of a mouse model of temporal lobe epilepsy.
Muthu D Bhaskaran, Bret N Smith. Exp Neurol 2010
Muthu D Bhaskaran, Bret N Smith. Exp Neurol 2010
11
GPR55 is a cannabinoid receptor that increases intracellular calcium and inhibits M current.
Jane E Lauckner, Jill B Jensen, Huei-Ying Chen, Hui-Chen Lu, Bertil Hille, Ken Mackie. Proc Natl Acad Sci U S A 2008
Jane E Lauckner, Jill B Jensen, Huei-Ying Chen, Hui-Chen Lu, Bertil Hille, Ken Mackie. Proc Natl Acad Sci U S A 2008
9
Isolation and structure of a brain constituent that binds to the cannabinoid receptor.
W A Devane, L Hanus, A Breuer, R G Pertwee, L A Stevenson, G Griffin, D Gibson, A Mandelbaum, A Etinger, R Mechoulam. Science 1992
W A Devane, L Hanus, A Breuer, R G Pertwee, L A Stevenson, G Griffin, D Gibson, A Mandelbaum, A Etinger, R Mechoulam. Science 1992
9
Cannabinoids in the Treatment of Epilepsy: Hard Evidence at Last?
Emilio Perucca. J Epilepsy Res 2017
Emilio Perucca. J Epilepsy Res 2017
9
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors.
T V Zanelati, C Biojone, F A Moreira, F S Guimarães, Sâmia R L Joca. Br J Pharmacol 2010
T V Zanelati, C Biojone, F A Moreira, F S Guimarães, Sâmia R L Joca. Br J Pharmacol 2010
9
Cannabidiol, a non-psychotropic component of cannabis, attenuates vomiting and nausea-like behaviour via indirect agonism of 5-HT(1A) somatodendritic autoreceptors in the dorsal raphe nucleus.
E M Rock, D Bolognini, C L Limebeer, M G Cascio, S Anavi-Goffer, P J Fletcher, R Mechoulam, R G Pertwee, L A Parker. Br J Pharmacol 2012
E M Rock, D Bolognini, C L Limebeer, M G Cascio, S Anavi-Goffer, P J Fletcher, R Mechoulam, R G Pertwee, L A Parker. Br J Pharmacol 2012
9
Δ⁹-Tetrahydrocannabivarin suppresses in vitro epileptiform and in vivo seizure activity in adult rats.
Andrew J Hill, Samantha E Weston, Nicholas A Jones, Imogen Smith, Sarah A Bevan, Elizabeth M Williamson, Gary J Stephens, Claire M Williams, Benjamin J Whalley. Epilepsia 2010
Andrew J Hill, Samantha E Weston, Nicholas A Jones, Imogen Smith, Sarah A Bevan, Elizabeth M Williamson, Gary J Stephens, Claire M Williams, Benjamin J Whalley. Epilepsia 2010
12
Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.